Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
What's new in NMOSD and MOGAD?
Marignier R. Marignier R. Rev Neurol (Paris). 2024 Nov;180(9):957-962. doi: 10.1016/j.neurol.2024.08.004. Epub 2024 Sep 14. Rev Neurol (Paris). 2024. PMID: 39277477 Free article. Review.
Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders.
Ciron J, Audoin B, Bourre B, Brassat D, Durand-Dubief F, Laplaud D, Maillart E, Papeix C, Vukusic S, Zephir H, Marignier R, Collongues N; NOMADMUS group, under the aegis of OFSEP, SFSEP. Ciron J, et al. Among authors: marignier r. Rev Neurol (Paris). 2018 Apr;174(4):255-264. doi: 10.1016/j.neurol.2017.11.005. Epub 2018 Mar 30. Rev Neurol (Paris). 2018. PMID: 29606320 Review. English.
"Myelitis migrans": A rare cause of treatable myelitis.
Jaulent P, Pegat A, Grosset-Janin C, Durand-Dubief F, Vukusic S, Marignier R. Jaulent P, et al. Among authors: marignier r. Rev Neurol (Paris). 2018 Dec;174(10):745-747. doi: 10.1016/j.neurol.2017.12.005. Epub 2018 Aug 22. Rev Neurol (Paris). 2018. PMID: 30143322 No abstract available.
Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
Poupart J, Giovannelli J, Deschamps R, Audoin B, Ciron J, Maillart E, Papeix C, Collongues N, Bourre B, Cohen M, Wiertlewski S, Outteryck O, Laplaud D, Vukusic S, Marignier R, Zephir H; NOMADMUS study group. Poupart J, et al. Among authors: marignier r. Neurology. 2020 Apr 14;94(15):e1645-e1656. doi: 10.1212/WNL.0000000000009245. Epub 2020 Mar 13. Neurology. 2020. PMID: 32170036
MRI characteristics of MOG-Ab associated disease in adults: An update.
Shor N, Deschamps R, Cobo Calvo A, Maillart E, Zephir H, Ciron J, Papeix C, Durand-Dubief F, Ruet A, Ayrignac X, Cohen M, Deiva K, Laplaud D, Bourre B, Audoin B, Collongues N, Vukusic S, Cotton F, Marignier R; NOMADMUS study group. Shor N, et al. Among authors: marignier r. Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):39-50. doi: 10.1016/j.neurol.2020.06.016. Epub 2020 Oct 10. Rev Neurol (Paris). 2021. PMID: 33046261 Review.
The long-term outcome of MOGAD: An observational national cohort study of 61 patients.
Deschamps R, Pique J, Ayrignac X, Collongues N, Audoin B, Zéphir H, Ciron J, Cohen M, Aboab J, Mathey G, Derache N, Laplaud D, Thouvenot E, Bourre B, Ruet A, Durand-Dubief F, Touitou V, Vignal-Clermont C, Papeix C, Gout O, Marignier R, Maillart E; NOMADMUS study group. Deschamps R, et al. Among authors: marignier r. Eur J Neurol. 2021 May;28(5):1659-1664. doi: 10.1111/ene.14746. Epub 2021 Feb 19. Eur J Neurol. 2021. PMID: 33528851
Acute and subacute myelopathy.
Marignier R. Marignier R. Rev Neurol (Paris). 2021 May;177(5):557-566. doi: 10.1016/j.neurol.2020.08.003. Epub 2020 Oct 21. Rev Neurol (Paris). 2021. PMID: 34024334 Review.
238 results